You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

EFUDEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Efudex patents expire, and when can generic versions of Efudex launch?

Efudex is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in EFUDEX is fluorouracil. There are fifteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Efudex

A generic version of EFUDEX was approved as fluorouracil by FRESENIUS KABI USA on September 30th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EFUDEX?
  • What are the global sales for EFUDEX?
  • What is Average Wholesale Price for EFUDEX?
Summary for EFUDEX
Drug patent expirations by year for EFUDEX
Drug Prices for EFUDEX

See drug prices for EFUDEX

Recent Clinical Trials for EFUDEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of ChicagoPhase 1
National Cancer Institute (NCI)N/A
UNC Lineberger Comprehensive Cancer CenterN/A

See all EFUDEX clinical trials

Pharmacology for EFUDEX

US Patents and Regulatory Information for EFUDEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch EFUDEX fluorouracil CREAM;TOPICAL 016831-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch EFUDEX fluorouracil SOLUTION;TOPICAL 016831-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch EFUDEX fluorouracil SOLUTION;TOPICAL 016831-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.